供应商 · 未分类 · 工业生物技术与生物基材料

Borregaard

鲍利葛（Borregaard）拥有并运营世界最先进的生物精炼厂：以天然、可持续的原料生产先进且环保的生物化学品、生物材料和生物乙醇，替代石油基产品，并在添加剂与精细化学品领域占据强势地位。公司在欧洲、美国、亚洲和非洲 16 个国家设有工厂和销售办事处，雇用 1,100 名员工。健康、安全与环境纳入公司业务计划，公司从事会责任，积极推动健全的环境与社会发展。按照专业化与价值提升战略，公司在研发上投入可观资源——研发在挪威、西班牙、南非和美国的研究中心进行，并与多国客户、大学和研究机构广泛合作。

运营中挪威欧洲成立 2012 已上市员工: 1,177 (at the end of 2025) 营收: NOK 7.7 billion (2025) 核实于 2026-10-05

简介

行业: 生物炼制, 化妆品, 能源, 渔业与水产养殖, 食品配料, 工业化学, 包装与塑料, 纺织与皮革
主题: 有机酸与生物基化学品, 纤维素、粘胶与莱赛尔纤维, 生物乙醇, 糖、棕榈油与农产品加工
角色: 未分类
为何属于生物经济: Borregaard（鲍利葛）是生物精炼企业，以可再生木材原料生产生物化学品、生物材料和生物乙醇。

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

子公司: Borregaard AS

状态

2026-06 最新状态: 2026年第二季度，鲍利葛对其在 Alginor ASA 的投资确认 3.37 亿挪威克朗的减值损失，并提出对其持股进行重组。 ↗ ↗ ↗

近期新闻 5

由自动检索获得；摘要为机器生成的英文。标题含公司名称，或摘要以该公司为主体——引用前请核对原文。

2026-09-28 Borregaard Secures NOK 1.5bn Sustainability-Linked Credit Facilities tipranks.com
Borregaard has secured NOK 1.5 billion in sustainability-linked revolving credit facilities, with loan costs tied to its progress on reducing greenhouse gas emissions, injuries, and organic discharges, signaling stronger financing terms tied to ESG progress and reinforcing its …
2026-08-10 Borregaard ASA: EBITDA1 of NOK 405 million in the 4th quarter 2025 - Inderes inderes.fi
Borregaard ASA reported a 4Q2025 EBITDA1 of NOK 405 million on revenues of NOK 1,833 million, with BioMaterials improving and BioSolutions and Fine Chemicals offset by higher costs; net earnings were negative before tax due to a NOK 245 million impairment of bio-based start-ups. …
2026-07-23 GranBio Reaches Settlement with Borregaard and Grants License prweb.com
Borregaard reached a mutual license agreement with GranBio in a patent dispute, obtaining a contractual license related to GranBio’s sulfite-based nanocellulose technology (European Patent EP/NO 3089998).
2026-04-24 Borregaard ASA: EBITDA1 of NOK 428 million in the 1st quarter - Inderes inderes.se
Borregaard ASA reported Q1 2026 EBITDA (EBITDA1) of NOK 428 million on revenues of NOK 2,005 million, with profit before tax of NOK 230 million and EPS of NOK 1.82. The results show mixed momentum: BioSolutions’ volumes were down due to delayed value chains, BioMaterials …
2026-04-23 Review of financial reporting - Borregaard ASA live.euronext.com
Borregaard ASA received a compliance review from Finanstilsynet noting that the Q4 2025 interim report’s impairment of NOK 225 million related to its Alginor ASA investment lacked sufficient disclosure. The regulator required additional information, which Borregaard provided in …

关系网络：股东、合作伙伴、同类

股权与投资方 2

投资方	Folketrygdfondet
子公司	Borregaard AS

合作与交易 1

交易对手	Hatteland (in relation to Alginor restructuring) …Borregaard recognized an impairment loss of NOK 337 million on its investment in Alginor ASA in the second quarter of 2026 and proposed a restructuring of its ownership.…

公司信息

注册编号

LEI: 5967007LIEEXZXGYXC05 官方登记 ↗
Organisation number: 998 753 562 官方登记 ↗

融资

最近一轮: Grant · 2025-10-25 · US$ 1.5 M
累计融资: US$ 65.1 M

来自自动化调研（公司网站、公告、商业企业数据库），未经人工核对。注册编号请以官方登记为准。

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录